Related references
Note: Only part of the references are listed.A phase I/II study of intrathecal idursulfase-IT in children with severe mucopolysaccharidosis II
Joseph Muenzer et al.
GENETICS IN MEDICINE (2016)
A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules
Aleksanteri Aspelund et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Nonclinical evaluation of CNS-administered TPP1 enzyme replacement in canine CLN2 neuronal ceroid lipofuscinosis
Brian R. Vuillemenot et al.
MOLECULAR GENETICS AND METABOLISM (2015)
Convection-Enhanced Drug Delivery to the Brain: Therapeutic Potential and Neuropathological Considerations
Neil U. Barua et al.
BRAIN PATHOLOGY (2014)
Intrathecal Rituximab Therapy in Multiple Sclerosis: Review of Evidence Supporting the Need for Future Trials
Mickael Bonnan et al.
CURRENT DRUG TARGETS (2014)
Treatment of lysosomal storage disorders: successes and challenges
Carla E. M. Hollak et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2014)
Enzyme Replacement Therapy Attenuates Disease Progression in a Canine Model of Late-Infantile Neuronal Ceroid Lipofuscinosis (CLN2 Disease)
Martin L. Katz et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2014)
The blood-brain barrier: Structure, function and therapeutic approaches to cross it
Marta Tajes et al.
MOLECULAR MEMBRANE BIOLOGY (2014)
Intrathecal AAV Serotype 9-mediated relivery of shRNA Against TRPV1 Attenuates Thermal Hyperalgesia in a Mouse Model of Peripheral Nerve Injury
Takashi Hirai et al.
MOLECULAR THERAPY (2014)
Delivery of an enzyme-IGFII fusion protein to the mouse brain is therapeutic for mucopolysaccharidosis type IIIB
Shih-hsin Kan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Recombinant human tripeptidyl peptidase-1 infusion to the monkey CNS: Safety, pharmacokinetics, and distribution
Brian R. Vuillemenot et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2014)
You Shall Not Pass-tight junctions of the blood brain barrier
Hans-Christian Bauer et al.
FRONTIERS IN NEUROSCIENCE (2014)
Evaluating glymphatic pathway function utilizing clinically relevant intrathecal infusion of CSF tracer
Lijun Yang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study (vol 12, pg 435, 2013)
T. M. Miller et al.
LANCET NEUROLOGY (2013)
STP Position Paper: Recommended Practices for Sampling and Processing the Nervous System (Brain, Spinal Cord, Nerve, and Eye) during Nonclinical General Toxicity Studies
Brad Bolon et al.
TOXICOLOGIC PATHOLOGY (2013)
An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study
Timothy M. Miller et al.
LANCET NEUROLOGY (2013)
A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid β
Jeffrey J. Iliff et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Safety evaluation of chronic intrathecal administration of heparan N-sulfatase in juvenile cynomolgus monkeys
Richard W. Pfeifer et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2012)
Recent insights into a new hydrodynamics of the cerebrospinal fluid
Marin Bulat et al.
BRAIN RESEARCH REVIEWS (2011)
Complete response in HER2+leptomeningeal carcinomatosis from breast cancer with intrathecal trastuzumab
Mafalda Oliveira et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Intrathecal tripeptidyl-peptidase 1 reduces lysosomal storage in a canine model of late infantile neuronal ceroid lipofuscinosis
Brian R. Vuillemenot et al.
MOLECULAR GENETICS AND METABOLISM (2011)
Large-volume Intrathecal Enzyme Delivery Increases Survival of a Mouse Model of Late Infantile Neuronal Ceroid Lipofuscinosis
Su Xu et al.
MOLECULAR THERAPY (2011)
Morphologic Changes Associated with Intrathecal Catheters for Direct Delivery to the Central Nervous System in Preclinical Studies
Mark T. Butt
TOXICOLOGIC PATHOLOGY (2011)
Safety Evaluation of Chronic Intrathecal Administration of Idursulfase-IT in Cynomolgus Monkeys
Brian R. Felice et al.
TOXICOLOGIC PATHOLOGY (2011)
Clarifying lysosomal storage diseases
Mark L. Schultz et al.
TRENDS IN NEUROSCIENCES (2011)
Anatomy and physiology of cerebrospinal fluid
L. Sakka et al.
EUROPEAN ANNALS OF OTORHINOLARYNGOLOGY-HEAD AND NECK DISEASES (2011)
The formation of cerebrospinal fluid: Nearly a hundred years of interpretations and misinterpretations
D. Oreskovic et al.
BRAIN RESEARCH REVIEWS (2010)
Intrathecal administration of recombinant human N-acetylgalactosamine 4-sulfatase to a MPS VI patient with pachymeningitis cervicalis
Maria Veronica Munoz-Rojas et al.
MOLECULAR GENETICS AND METABOLISM (2010)
Effectiveness of intrathecal rituximab in patients with acute lymphoblastic leukaemia relapsed to the CNS and resistant to conventional therapy
Jose Carlos Jaime-Perez et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Comparison of cerebrospinal fluid obtained by ventricular endoscopy and by lumbar puncture in patients with hydrocephalus secondary to neurocysticercosis
Jaime G. Torres-Corzo et al.
SURGICAL NEUROLOGY (2009)
Intrathecal Enzyme Replacement Therapy in a Patient With Mucopolysaccharidosis Type I and Symptomatic Spinal Cord Compression
Maria-Veronica Munoz-Rojas et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2008)
Ziconotide: an update and review
Jason A. Williams et al.
EXPERT OPINION ON PHARMACOTHERAPY (2008)
Successful management of difficult infusion-associated reactions in a young patient with mucopolysaccharidosis type VI receiving recombinant human arylsulfatase B (galsulfase [Naglazyme])
Katherine H. Kim et al.
PEDIATRICS (2008)
Intrathecal enzyme replacement therapy: Successful treatment of brain disease via the cerebrospinal fluid
Patricia Dickson et al.
MOLECULAR GENETICS AND METABOLISM (2007)
Phase I study of intraventricular administration of rituximab in patients with recurrent CNS and intraocular lymphoma
James L. Rubenstein et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Nonclinical safety of ziconotide: An intrathecal analgesic of a new pharmaceutical class
Michael J. Skov et al.
INTERNATIONAL JOURNAL OF TOXICOLOGY (2007)
Time course and role of morphine dose and concentration in intrathecal granuloma formation in dogs - A combined magnetic resonance imaging and histopathology investigation
Jeffrey W. Allen et al.
ANESTHESIOLOGY (2006)
An epidemiological study of motor neuron disease in Hong Kong
GCY Fong et al.
AMYOTROPHIC LATERAL SCLEROSIS (2005)
Autonomic dysfunction in ALS: A preliminary study on the effects of intrathecal BDNF
M Beck et al.
AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS (2005)
Comparison of ventricular and lumbar cerebrospinal fluid T cells in non-inflammatory neurological disorder (NIND) patients
JJ Provencio et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Fluoro-Jade C results in ultra high resolution and contrast labeling of degenerating neurons
LC Schmued et al.
BRAIN RESEARCH (2005)
Intraputamenal infusion of glial cell line-derived neurotrophic factor in PD: A two-year outcome study
NK Patel et al.
ANNALS OF NEUROLOGY (2005)
Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS
E Storkebaum et al.
NATURE NEUROSCIENCE (2005)
Modulation of drug transporters at the blood-brain barrier
G Fricker et al.
PHARMACOLOGY (2004)
Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD
JG Nutt et al.
NEUROLOGY (2003)
Application of silver degeneration stains for neurotoxicity testing
RC Switzer
TOXICOLOGIC PATHOLOGY (2000)
Share Paper
